Open mitochondrial research · Plain-language explainer

Published on Zenodo · October 15, 2026

Compartment-Resolved ERK Signaling in Oxidant-Linked Mitochondrial Outcomes

Andrew Friedl

Abstract

**Background:** Oxidative-stress studies often compress reactive oxygen species, ERK phosphorylation, mitochondrial dysfunction, mitophagy and cell fate into one injury narrative. That compression leaves unresolved whether compartment-localized ERK activity helps set mitochondrial endpoint identity or merely marks generic upstream damage.

**Objective:** This working paper retains the selected question: Under matched oxidant or mitochondrial-stress conditions, does compartment-localized ERK activity set mitochondrial respiration, mitophagy, ATP-maintenance or permeability-transition endpoints rather than merely marking generic ROS injury?

**Methods:** PubMed, PubMed Central, prior Mito Map bundles, the reviewed candidate-selection dossier and six complete public primary PMC texts were checked on 2026-10-10. Endpoint classes were renal complex 1 respiration and ATP production, neuronal ERK2-linked mitophagy, macrophage ATP and membrane-potential maintenance, redox-compartment ERK phosphorylation, ERK5/NRF2 antioxidant response, and tumor-cell permeability-transition sensitivity. The analysis was a source-coded competing-model synthesis and measurement-rule analysis; no pooled effect size, raw-image reanalysis, clinical inference, treatment recommendation or wet-lab validation was performed.

**Results:** In oxidant-injured renal proximal tubular cells, MEK/ERK inhibition restored respiration, complex 1 activity and ATP production, while constitutively active MEK1 suppressed respiration in noninjured cells [1]. In SH-SY5Y neuronal cells, mitochondrial ERK2 activity was sufficient to recapitulate 6-OHDA-linked mitophagy and autophagic cell death [2]. Boundary evidence prevented a universal ERK-injury claim: ERK activity maintained ATP and mitochondrial membrane potential in human alveolar macrophages [3], redox state altered ERK phosphorylation by compartment in lung cells [4], complex 1 activity induced an ERK5/NRF2 antioxidant response without requiring de novo ROS [5], and mitochondrial ERK desensitized tumor-cell permeability transition through GSK-3 and cyclophilin D [6].

**Conclusions:** Current primary evidence supports a bounded discriminator rather than a new biological proof. Where compartment ERK is measurable, oxidant-linked mitochondrial endpoints should be interpreted with ERK localization, perturbation, viability, mitochondrial-content and endpoint-specific controls before being assigned to generic ROS injury. The claim would weaken if matched experiments showed no ERK-perturbation effect on respiration, mitophagy, ATP maintenance or pore sensitivity after ROS burden, viability, mitochondrial mass and off-target kinase controls were applied.

Download the manuscript PDF

DOI: 10.5281/zenodo.23400942

Read the full paperRead the public summary

The paper at a glance

The question

Reactive oxygen species are chemically reactive molecules made during stress and normal metabolism. Many studies see them together with ERK signaling and mitochondrial changes. This paper explains why those observations should not be treated as one generic damage story.

Main takeaway

ERK signaling sometimes worsened a mitochondrial endpoint, sometimes supported ATP or antioxidant defenses, and sometimes protected tumor cells from pore opening. The direction depended on cell type, ERK form, location and measured endpoint.

Important caution

This paper does not show that changing ERK is a treatment. It does not prove a universal rule for people. It does not pool statistics or remeasure raw images.

Why this matters

Reactive oxygen species are chemically reactive molecules made during stress and normal metabolism. Many studies see them together with ERK signaling and mitochondrial changes. This paper explains why those observations should not be treated as one generic damage story.

How the research was done

Six public primary studies in cells and mouse tissue were compared. They involved kidney tubule cells, neuronal cells, human lung macrophages, murine lung cells, blood or liver-related cell systems, and tumor-cell models. No patient treatment was tested.

What the researchers found

ERK signaling sometimes worsened a mitochondrial endpoint, sometimes supported ATP or antioxidant defenses, and sometimes protected tumor cells from pore opening. The direction depended on cell type, ERK form, location and measured endpoint.

What this does not prove

This paper does not show that changing ERK is a treatment. It does not prove a universal rule for people. It does not pool statistics or remeasure raw images.

What researchers should test next

Useful follow-up studies would match stress dose and timing, then measure ERK location and a specific mitochondrial endpoint such as respiration, mitophagy, ATP or pore sensitivity.

Helpful definitions

Key terms in plain English

MitochondriaStructures inside cells that convert fuel into energy the cell can use.

See the evidence

Visual findings

Visual finding 1. Analysis process
Visual finding 2. Concept summary

For non-specialists

What this could mean for patients and families

The practical message is about research interpretation. A mitochondrial stress result should not be called simple oxidative damage unless the study also checks whether ERK location or activity changes the endpoint being measured.

  • Did the study measure ERK location or only total ERK activation?
  • Which mitochondrial endpoint was measured: energy production, mitophagy, antioxidant response or pore opening?
  • Were cell injury and mitochondrial amount controlled before interpreting the ERK result?
Track symptoms and function over time →Join Mito Map as a researcher →